Navigation Links
Netherlands to lift livestock restrictions over avian influenza

According to the agriculture ministry in the Netherlands, the nation was ready to ease some restrictions imposed to curb a mildly pathogenic strain of bird flu, with other// measures on poultry due to follow next month.

On August 1, traces of the mildly pathogenic H7N7 strain, were found on a farm in Voorthuizen, situated in the centre of the country. However, this strain is not potentially harmful to humans, unlike the H5N1strain.

Though no animals fell sick, the fear of the virus getting mutated was there. So, around 25,000 chickens were culled and livestock markets in the region and sales of animals from nearby farms were banned. These restrictions are to be lifted today.

The ministry has made an announcement this week that from September1, all poultry not vaccinated against bird flu must be detained. This has to be done to avoid the risk of the virus being spread during migration season.

A pandemic of H7N7 virus hit the Netherlands in 2003. As a result, 25million birds were culled, which amounts to one-fourth of the country’s poultry population then.
'"/>




Page: 1

Related medicine news :

1. Mercy killing for newborn with incurable disease in Netherlands
2. Norovirus outbreak results in hospital visit restrictions
3. Vaccine to protect birds against avian flu, engineered
4. Global avian flu database
5. Hidden influenza virus protein found
6. It is safe to take influenza vaccine during pregnancy
7. Mysterious viral outbreak in Toronto, influenza ruled out
8. Catechins in green tea show antiviral effect on influenza virus
9. Old flu drugs not effective against seasonal influenza
10. Quebec arming itself to combat a potential influenza pandemic
11. influenza Vaccination Needed to Stop Flu Bug
Post Your Comments:
Other Medicine News:Health News:Academic Leader Joins Medical Management International Board of Directors 2Health News:Academic Leader Joins Medical Management International Board of Directors 3Health News:Hardened Arteries Threaten Obese, Diabetic Youth 2Health News:Hardened Arteries Threaten Obese, Diabetic Youth 3Health News:Compirion Healthcare Cuts Emergency Department Throughput by 50% at the Medical Center of Central Georgia 2Health News:Compirion Healthcare Cuts Emergency Department Throughput by 50% at the Medical Center of Central Georgia 3Health News:Compirion Healthcare Cuts Emergency Department Throughput by 50% at the Medical Center of Central Georgia 4Health News:Compirion Healthcare Cuts Emergency Department Throughput by 50% at the Medical Center of Central Georgia 5Health News:New Program Offsets Risks of 'Do-It-Yourself' Gestational Surrogacy 2Health News:NEJM study finds drug-eluting stents more effective than bare-metal stents in heart attack patients 2
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8Handwriting Skills May Lag in Kids With Autism 61014 1Handwriting Skills May Lag in Kids With Autism 61014 2Doctors Spending More Time Now With Patients 61011 1Doctors Spending More Time Now With Patients 61011 2Doctors Spending More Time Now With Patients 61011 3Fitness com au Poll Finds 80 25 Blame Parents For Our Overweight Kids 61009 1Fitness com au Poll Finds 80 25 Blame Parents For Our Overweight Kids 61009 2